Unveiling pembrolizumab effectiveness in diverse subtypes of MSI-high endometrial cancers.

Published in: Journal of gynecologic oncology (2024)

methylation cases due to its high sensitivity. Further studies are needed to determine whether EPM2AIP1 IHC can predict pembrolizumab efficacy.

Keyphrases